To ask the Secretary of State for Health how many licences for parallel imports of medicines have been granted by his Department.
Information about the number of licences for parallel imports granted by the Medicines Control Agency is published regularly in MAIL (Medicines Act Information Letter). The most recent edition (April 1990) states that as at 31 January 1990, 2,200 licences had been issued. A copy is available in the Library.
To ask the Secretary of State for Health what representations he has received on the reasons why the new precautionary measures required by the Medicines Control Agency to detect possible counterfeit
| £ | |||||
| Group | 1 September 1986 | 1 September 1987 | 1 September 1988 | 1 September 1989 | 1 January 1990 |
| District General Managers | |||||
| DGM 1 | |||||
| From | 33,500 | 35,175 | 37,110 | 39,520 | 40,500 |
| To | 44,220 | 46,431 | 48,985 | 56,513 | 58,500 |
| DGM 2 | |||||
| From | 32,000 | 33,600 | 35,450 | 37,750 | 38,250 |
| To | 42,240 | 44,352 | 46,794 | 53,983 | 55,250 |
| DGM 3 | |||||
| From | 30,500 | 32,025 | 33,790 | 35,990 | 35,000 |
| To | 40,260 | 42,273 | 44,603 | 51,466 | 50,750 |
| Unit General Managers | |||||
| UGM 1 | |||||
| From | 28,000 | 29,400 | 31,020 | 33,040 | 35,000 |
| To | 38,640 | 40,572 | 42,808 | 49,395 | 50,750 |
| UGM 2 | |||||
| From | 25,500 | 26,775 | 28,250 | 30,090 | 30,750 |
| To | 35,190 | 36,950 | 38,985 | 44,985 | 44,500 |
| UGM 3 | |||||
| From | 23,000 | 24,150 | 25,480 | 27,140 | 27,750 |
| To | 31,740 | 33,327 | 35,162 | >40,574 | 40,250 |
| UGM 4 | |||||
| From | 20,000 | 21,000 | 22,160 | 23,600 | 24,000 |
| To | 27,600 | 28,980 | 30,581 | 35,282 | 34,750 |
| UGM 5 | |||||
| From | 16,500 | 17,325 | 18,280 | 19,470 | — |
| To | 22,770 | 23,909 | 25,226 | 29,108 | — |
Notes:
1. The higher figures shown include the maximum loading for job weight and the maximum possible performance-related pay.
2. The UGM 5 group was merged with UGM 4 from 1 January 1990. This was one of a number of changes introduced to simplify the pay system and make it more flexible.
medicines among parallel imports from European Community member states do not require batch analysis of all such imports.
No formal representations have been received.